ArticleArthritis research & therapy2023

Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA Registry.

Dimitrios A Pappas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.